We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Brain Mapping Study Using Large-Scale MRI Images Aims to Detect Alzheimer’s Disease Earlier

By MedImaging International staff writers
Posted on 23 Mar 2022
Image: Research to map the brain to detect Alzheimer’s earlier (Photo courtesy of Pexels)
Image: Research to map the brain to detect Alzheimer’s earlier (Photo courtesy of Pexels)

About 50 million people worldwide are living with Alzheimer’s and forms of dementia, according to the Alzheimer’s Association. The disease kills more people than breast and prostate cancers combined. Now, a new study will map the brain using large-scale magnetic resonance (MRI) images in an effort to identify stable brain landmarks called ‘anchor-nodes’ and detect Alzheimer’s disease earlier.

The five-year, USD 2.7 million collaborative project, titled “Mapping Trajectories of Alzheimer's Progression via Personalized Brain Anchor-Nodes” will be led by Dajiang Zhu, a computer science and engineering assistant professor at the University of Texas at Arlington (Arlington, TX, USA). The researchers will use large-scale MRI images to map the brain upon onset and during the disease at multiple clinical stages. The team will use computational approaches to identify a set of stable brain landmarks as “anchor-nodes” and construct novel imaging-based biomarkers across a wide spectrum of Alzheimer’s development.

“This is a new approach to the disease,” said Zhu. “Diagnosis of Alzheimer’s isn’t challenging. It’s catching it as early as possible, or even at the asymptomatic stage, that is the challenge. Those biomarkers could give us insight as to where patients are in the life of the disease. We want to start being proactive in treating this disease, not reactive. If we can delay the onset of the disease, it could lead to better lives for so many people.”

Related Links:
University of Texas at Arlington 

Mammo DR Retrofit Solution
DR Retrofit Mammography
Biopsy Software
Affirm® Contrast
X-ray Diagnostic System
FDX Visionary-A
Mammography System (Analog)
MAM VENUS

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.